A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing
- 9 March 2004
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (10) , 3504-3509
- https://doi.org/10.1073/pnas.0400182101
Abstract
Dinucleotide repeats are ubiquitous features of eukaryotic genomes that are not generally considered to have functional roles in gene expression. However, the highly variable nature of dinucleotide repeats makes them particularly interesting candidates for modifiers of RNA splicing when they are found near splicing signals. An example of a variable dinucleotide repeat that affects splicing is a TG repeat located in the splice acceptor of exon 9 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Higher repeat numbers result in reduced exon 9 splicing efficiency and, in some instances, the reduction in full-length transcript is sufficient to cause male infertility due to congenital bilateral absence of the vas deferens or nonclassic cystic fibrosis. Using a CFTR minigene system, we studied TG tract variation and observed the same correlation between dinucleotide repeat number and exon 9 splicing efficiency seen in vivo. Replacement of the TG dinucleotide tract in the minigene with random sequence abolished splicing of exon 9. Replacements of the TG tract with sequences that can self-base-pair suggested that the formation of an RNA secondary structure was associated with efficient splicing. However, splicing efficiency was inversely correlated with the predicted thermodynamic stability of such structures, demonstrating that intermediate stability was optimal. Finally, substitution with TA repeats of differing length confirmed that stability of the RNA secondary structure, not sequence content, correlated with splicing efficiency. Taken together, these data indicate that dinucleotide repeats can form secondary structures that have variable effects on RNA splicing efficiency and clinical phenotype.Keywords
This publication has 37 references indexed in Scilit:
- Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or BenignAmerican Journal of Human Genetics, 2004
- Novel functional role of CA repeats and hnRNP L in RNA stabilityRNA, 2003
- HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeatsNature Structural & Molecular Biology, 2002
- Atypical 5′ Splice Sites Cause CFTR Exon 9 To Be Vulnerable to SkippingAmerican Journal of Human Genetics, 2002
- Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.Journal of Clinical Investigation, 1998
- Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1995
- Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model.Genes & Development, 1994
- Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNANature Genetics, 1993
- Tissue-Specific Splicing in Vivo of the β-Tropomyosin Gene: Dependence on an RNA Secondary StructureScience, 1991
- Effect of mutations at the lariat branch acceptor site on β-globin pre-mRNA splicing in vitroNature, 1986